AICDA and cancer: Importantly, mutational signature comparisons unveiled a major impact of HR dysfunction, NER-TCR and the AID/APOBEC family of cytidine deaminases on head-on TRCs in cancer cells (Fig. 6a and Supplementary Figs. 9 and 10).